drugset / Trial / NCT01503606

Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane

NCT01503606

Phase 3 Completed 151 enrolled Samsung Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the neonatal outcome and infant neurologic outcome whose mother were treated with cefazolin plus clarithromycin for one week or until delivery after preterm premature rupture of membrane.

Timeline

Start
2011-10
Primary completion
2020-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cefazolin Small molecule 1 g Intravenous
Comparator Clarithromycin Small molecule 500 mg Oral